Cholera
Therapeutic area
Gastroenterology
Rare disease
Yes
- Definition
- Cholera is an infectious disease, caused by intestinal infection with Vibrio cholerae, characterized by massive watery diarrhea and severe dehydration that can lead to shock and death if left untreated.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- Yes
- Listing at source
- Listed
- Condition name
- Cholera
- Therapeutic area
- Gastroenterology
- cholera
- Cholera (Disorder)
- cholera due to Vibrio cholerae
- Vibrio cholerae caused disease or disorder
- Vibrio cholerae disease or disorder
- Vibrio Cholerae Infection
- Vibrio cholerae infectious disease
- Severity
- Severe
- Acquired
- Inflammatory
Sources for recorded values
- Gastroenterology
- Infectious Disease
Sources for recorded values
- MONDO ID
- MONDO:0015766
- Parent condition
- MONDO:0000314
Related records
Broader conditions (18)
- Bacterial infectious disease
- Digestive system disorder
- Digestive system infectious disorder
- Disease
- Disease by body system or component
- Disease by developmental or physiological process
- Disease by etiologic mechanism
- Disease of primarily extrinsic mechanism
- Gastroenteritis
- Gastrointestinal mucositis
- Human disease
- Infectious disease
- Inflammatory disease
- Intestinal disorder
- Intestinal infectious disease
- Mucositis
- Primary bacterial infectious disease
- Vibrio infectious disease
Trials (77)
- A Phase 3 Lot to Lot Consistency Study of Live Oral Cholera Vaccine, PXVX0200 in Healthy Adults
- A Phase III Randomized, Modified Double-blind, Multi-centric, Comparative Study, to Evaluate the Non-inferiority of Immunogenicity and Safety of Hillchol® (BBV131)to Shanchol™ Along With Lot-to-lot Consistency of Hillchol®(BBV131).
- A Study of Live Oral Cholera Vaccine, PXVX200 in Healthy Older Adults
- A Study of Two Doses of Oral Cholera Vaccine (Shanchol™) in Subjects Aged 1 Year and Older in Dominican Republic
- A Study of Two Doses of Oral Cholera Vaccine (Shanchol™) in Subjects Aged 1 Year and Older in the Philippines
- A Study to Evaluate Safety and Immunogenicity of the Bivalent Killed Whole Cell Oral Cholera Vaccine in Adults and Children
- Assessment of a Novel Fixed-dose Combination (FDC) Drug VR-AD-1005 for the Treatment of Acute Watery Diarrhea in Cholera
- Bridging Study for Killed Oral Cholera Vaccine in Ethiopia
- Cholera Anti-Secretory Treatment Trial
- Cholera Control by Case-area Targeted Interventions (CATIs)
- Cholera Vaccine Investment Strategy in Bangladesh
- Cholera-Hospital-Based-Intervention-for-7-days
- Cholera-Hospital-Based-Intervention-for-7-Days (CHoBI7) Water, Sanitation, and Hygiene (WASH) Case Area Targeted Intervention (CATI)
- Ciprofloxacin Multiple Dose for Adult Cholera
- Co-administration Study of OCV, TCV and MR
- Effect of Extended Dose Intervals on the Immune Response to Oral Cholera Vaccine
- Effect of Probiotic on Immunogenicity of Oral Cholera Vaccine
- Effectiveness of a Bivalent Killed Whole Cell Based Oral Cholera Vaccine
- Efficacy of Benefiber-Added, Reduced-Osmolarity WHO-ORS in the Treatment of Cholera in Adults
- Efficacy of iOWH032 in Dehydrating Cholera